The NKT cell ligand αgalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response

Autor: Knothe, S., Mutschler, V., Rochlitzer, S., Winkler, C., Ebensen, T., Guzman, C.A., Hohlfeld, J., Braun, A., Muller, M.
Zdroj: In Vaccine 2011 29(25):4249-4255
Databáze: ScienceDirect